Michael H. Rabinowitz

Author

Also Known As

M H Rabinowitz, M Rabinowitz, M. H. RABINOWITZ, Michael H Rabinowitz, Michael H. Rabinowitz, Michael Rabinowitz, Rabinowitz, M.H.

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Johnson & Johnson (United States)Research Triangle Park Foundation GlaxoSmithKline (United States)University of California, Irvine Universitat Pompeu Fabra

About

Michael H. Rabinowitz is an author at Johnson & Johnson (United States) specializing in pharmacology, natural sciences, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	444
2	Natural Sciences	10	10	657
3	Biochemistry	9	9	432
4	Engineering	3	3	106
5	Biomolecular Engineering	3	3	106

Michael H. Rabinowitz

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Enantioselective Total Synthesis of (-)-Ptilomycalin A Larry E. Overman, Michael H. Rabinowitz, Paul A. Renhowe Journal of the American Chemical Society Medicinal ChemistryMolecular SciencesChemical MeasurementChemical AnalysisDonut Icon	1995	209
The first enantioselective total syntheses of the allopumiliotoxin A alkaloids 267A and 339B Steven W. Goldstein, Larry E. Overman, Michael H. Rabinowitz The Journal of Organic Chemistry Allopumiliotoxin ABioorganic ChemistryBiochemistryNatural SciencesAltmetric Attention Score	1992	83
Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases. James G. Conway, Robert Andrews, B Beaudet, PubMed Dual InhibitorSoluble TnfTnf-alpha-converting EnzymeImmunologyPathology	2001	75
Design of Selective and Soluble Inhibitors of Tumor Necrosis Factor-α Converting Enzyme (TACE) Michael H. Rabinowitz, Robert Andrews, J. David Becherer, Journal of Medicinal Chemistry Inhibitory ActivityMedicinal ChemistryPharmaceutical ScienceBioorganic ChemistryBiochemistry	2001	73
Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Terrance D. Barrett, Heather L. Palomino, Theresa I. Brondstetter, Molecular Pharmacology	2011	72
A Practical Entry to the Crambescidin Family of Guanidine Alkaloids. Enantioselective Total Syntheses of Ptilomycalin A, Crambescidin 657 and Its Methyl Ester (Neofolitispates 2), and Crambescidin 800 Donald S. Coffey, Andrew I. McDonald, Larry E. Overman, Journal of the American Chemical Society Earlier Total SynthesisMarine AlkaloidsBiochemistryCrambescidin FamilyMedicine	2000	62
Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues Mark D. Rosen, Hariharan Venkatesan, Hillary M. Peltier, ACS Medicinal Chemistry Letters Erythropoietin SecretionPharmacotherapyRedox BiologyOxidative StressSystems Pharmacology	2010	62
Efficient Total Syntheses of Pumiliotoxins A and B. Applications of Iodide-Promoted Iminium Ion−Alkyne Cyclizations in Alkaloid Construction Nan‐Horng Lin, Larry E. Overman, Michael H. Rabinowitz, Journal of the American Chemical Society Efficient Total SynthesesEngineeringBiochemistryNatural SciencesDiversity-oriented Synthesis	1996	60
Enantioselective Total Syntheses of Allopumiliotoxins 267A, 323B‘, and 339A. Application of Iodide-Promoted Iminium Ion−Alkyne Cyclizations for Forming Allopumiliotoxin A Alkaloids Christian Caderas, Renee M. Lett, Larry E. Overman, Journal of the American Chemical Society	1996	52
Studies toward the total synthesis of (+)-ptilomycalin A. Use of a tethered Biginelli condensation for the preparation of an advanced tricyclic intermediate Larry E. Overman, Michael H. Rabinowitz The Journal of Organic Chemistry Medicinal ChemistryMolecular SciencesAdvanced Tricyclic IntermediateChemical AnalysisNatural Sciences	1993	50

Page 1